Metastasis in Tumor Immunity: Current Perspectives
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Metastasis".
Deadline for manuscript submissions: 30 January 2026 | Viewed by 71
Special Issue Editors
2. German Cancer Consortium (DKTK), Heidelberg, im Neuenheimer Feld 280, 69120 Heidelberg, Germany
Interests: translational oncology; metastasis research, biomarker identification and analysis; cancer signaling; cancer therapy
Special Issues, Collections and Topics in MDPI journals
Interests: translational oncology; metastasis research, immuno-oncology
2. Experimental Pharmacology & Oncology Berlin-Buch GmbH, Robert-Rössle-Str. 10, 13125 Berlin-Buch, Germany
Interests: translational oncology; metastasis research; immuno-oncology; animal models
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer metastasis remains the most lethal attribute of tumors and critically limits therapeutic options and patient survival. One key feature of cancer cells and a prerequisite in efficient tumor growth and metastasis is the ability to evade immunological recognition. Importantly, the specific mechanistic interplay of metastasis-enabling tumor cells with the immune system is often overlooked in favor of a broader immune–oncological context. Furthering our understanding of these interactions will allow a better assessment of the risk of individual cancers and enable specific intervention strategies.
This Special Issue will provide a platform to share basic, translational and clinical developments focusing on metastatic processes and immune evasion.
We are pleased to invite you to contribute original studies, systematic reviews, and meta-analysis discussing state-of-the-art insights, as well as novel advances in tumor progression, metastasis, and the immune system.
Research areas of interest include, but are not limited to, the following:
- Underlying inflammatory processes enabling metastasis;
- Genetic or epigenetic alterations promoting metastasis and immune escape;
- Metabolic and immuno-metabolic drivers of metastasis or immune evasion;
- Tumor-immune microenvironment interactions;
- Intervention strategies focusing on immune evasion in a metastatic context;
- Impact of senescence on metastasis and anti-tumor immunity.
Prof. Dr. Ulrike Stein
Dr. Sebastian Torke
Prof. Dr. Wolfgang Walther
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immune escape
- immune evasion
- immune microenvironment
- intervention strategies
- senescence on metastasis
- anti-tumor immunity
- cellular interactions
- molecular interactions
- immune suppression
- immune checkpoints
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
